The scoping study's values must now be considered to be superseded:
845,000 recoverable ozs is too low based on the results received after the scoping study.
The gp of $2750 per oz is too low with the price now over $3000.
The running expenses are very solid with capital raised, apparently, with no further share dilution.
The NPV is discounted a further 8% for a 7 year net pre tax amount of $442 million. I'm confident that amount will double: ~ $800 million.
That's a dividend approaching 20c.
Feysville, the base metals and AG not included.
So, if not $2, then what?
The scoping study's values must now be considered to be...
Add AAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
-0.002(2.50%) |
Mkt cap ! $72.78M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.5¢ | $120.1K | 1.572M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12900 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 62000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
-0.002 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 7.9¢ | 7.6¢ | 124979 | ||
| Last updated 15.52pm 14/05/2024 ? | |||||
| AAR (ASX) Chart |